Invention Grant
- Patent Title: Composition for prevention or treatment of hyperlipidemia, fatty liver or obesity
-
Application No.: US13056805Application Date: 2009-07-31
-
Publication No.: US09669050B2Publication Date: 2017-06-06
- Inventor: Seung Woo Kang
- Applicant: Seung Woo Kang
- Applicant Address: KR Seoul
- Assignee: BENEBIOSIS CO., LTD.
- Current Assignee: BENEBIOSIS CO., LTD.
- Current Assignee Address: KR Seoul
- Agency: Harness, Dickey & Pierce, P.L.C.
- Priority: KR10-2008-0075659 20080801; KR10-2009-0032463 20090414
- International Application: PCT/KR2009/004301 WO 20090731
- International Announcement: WO2010/013978 WO 20100204
- Main IPC: A61K31/702
- IPC: A61K31/702 ; C07H3/06 ; A61K31/715 ; A61K31/7016 ; A23L33/10
Abstract:
Disclosed is a composition for prophylaxis or treatment of hyperlipidemia, fatty liver, cardiovascular disease, or obesity including a compound represented by General Formula I as an effective ingredient: General Formula I S-(MS)p-(MS)q wherein S represents sialic acid, and (MS)p and (MS)q independently represent a monosaccharide residue.
Public/Granted literature
- US20110135717A1 Composition for Prevention or Treatment of Hyperlipidemia, Fatty Liver or Obesity Public/Granted day:2011-06-09
Information query
